SCHEMBL3634458

SCHEMBL3634458

CN1CCN(C(C(=O)NNc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2cccnc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 2/20 0.69
SLC1A2 P43004 3/20 0.55
SLC1A3 P43003 2/20 0.53
SLC1A1 P43005 2/20 0.53
KCNH2 Q12809 1/20 0.53
ABCB1 P08183 1/20 0.47
CYP3A4 P08684 3/20 0.45
CYP3A5 P20815 3/20 0.45
LMNA P02545 5/20 0.44
TP53 P04637 5/20 0.44
MAPT P10636 3/20 0.44
THRB P10828 1/20 0.43
TACR1 P25103 1/20 0.42
HTR2A P28223 2/20 0.41
HTR2C P28335 2/20 0.41
KDR P35968 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3741445 0.88 GHSR (0.63) GHSRSLC1A2SLC1A3SLC1A1KCNH2
SCHEMBL3634157 0.86 GHSR (0.61) GHSRSLC1A2SLC1A3SLC1A1KCNH2
SCHEMBL3634225 0.85 GHSR (0.67) GHSRABCB1LMNAMAPTTACR1
SCHEMBL3638183 0.83 GHSR (0.71) GHSRSLC1A2SLC1A3SLC1A1ABCB1
SCHEMBL3743921 0.82 GHSR (1.00) GHSRSLC1A2KCNH2CYP3A4CYP3A5
SCHEMBL3741670 0.82 GHSR (1.00) GHSRSLC1A2KCNH2CYP3A4CYP3A5
SCHEMBL3640133 0.82 GHSR (1.00) GHSRSLC1A2KCNH2CYP3A4CYP3A5
SCHEMBL3635981 0.82 GHSR (1.00) GHSRSLC1A2KCNH2CYP3A4CYP3A5
SCHEMBL3737852 0.82 GHSR (0.63) GHSRTACR1
SCHEMBL3634475 0.82 GHSR (0.71) GHSRTACR1HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US claimed
EP-2167466-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR Glaxo Group Limited (GB) 2010-03-31 EP claimed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO claimed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
EP-2167466-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR Glaxo Group Limited (GB) 2010-03-31 EP disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R GHSR 2/4885SLC1A2 1370/4885SLC1A3 814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.